These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21350458)

  • 21. The biotechnology sector's craving for commercial expertise is fuelling a cultural exchange with drug industry.
    Smaglik P; Frantz S
    Nature; 2003 Apr; 422(6931):542-3. PubMed ID: 12673255
    [No Abstract]   [Full Text] [Related]  

  • 22. Biotech booms in China.
    Ellis S
    Nature; 2018 Jan; 553(7688):S19-S22. PubMed ID: 29345681
    [No Abstract]   [Full Text] [Related]  

  • 23. An interdisciplinary shift in demand for talent within the biotech industry.
    Nugent KL; Kulkarni A
    Nat Biotechnol; 2013 Sep; 31(9):853-5. PubMed ID: 24022161
    [No Abstract]   [Full Text] [Related]  

  • 24. Virtual recruitment.
    Mills E
    Nat Biotechnol; 2002 Aug; 20(8):853. PubMed ID: 12148015
    [No Abstract]   [Full Text] [Related]  

  • 25. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
    Scattereggia J
    IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hatteras rounds up $90 million to lead biotech rebound in North Carolina.
    Erickson D
    Nat Biotechnol; 2015 Nov; 33(11):1121-2. PubMed ID: 26544128
    [No Abstract]   [Full Text] [Related]  

  • 27. Biotech industry faces new bottleneck.
    Garber K
    Nat Biotechnol; 2001 Mar; 19(3):184-5. PubMed ID: 11231516
    [No Abstract]   [Full Text] [Related]  

  • 28. Biotech in Bangalore.
    Russo G
    Nature; 2008 Apr; 452(7187):660-1. PubMed ID: 18389533
    [No Abstract]   [Full Text] [Related]  

  • 29. Big biotech buys iconic genetics firm.
    Baker M
    Nature; 2012 Dec; 492(7429):321. PubMed ID: 23257857
    [No Abstract]   [Full Text] [Related]  

  • 30. California dreaming: San Diego.
    Smaglik P
    Nature; 2003 Mar; 422(6928):240-1. PubMed ID: 12634799
    [No Abstract]   [Full Text] [Related]  

  • 31. Biotech giant helps itself without swallowing Galapagos whole.
    Senior M
    Nat Biotechnol; 2019 Oct; 37(10):1104-1105. PubMed ID: 31578499
    [No Abstract]   [Full Text] [Related]  

  • 32. Deal watch: M&A activity in 2009.
    Walker J
    Nat Rev Drug Discov; 2010 Feb; 9(2):95. PubMed ID: 20118956
    [No Abstract]   [Full Text] [Related]  

  • 33. Success in an uneven market.
    Russo E
    Nature; 2003 Jul; 424(6948):597. PubMed ID: 12891372
    [No Abstract]   [Full Text] [Related]  

  • 34. Cheap at any price?
    Ledford H
    Nature; 2007 May; 447(7141):131. PubMed ID: 17495898
    [No Abstract]   [Full Text] [Related]  

  • 35. Row over industry link-up splits staff of Spanish lab.
    Fernandez Hermana LA
    Nature; 1994 Dec; 372(6507):586. PubMed ID: 7990935
    [No Abstract]   [Full Text] [Related]  

  • 36. A youthful field.
    Smaglik P
    Nature; 2002 Oct; 419(6908):3. PubMed ID: 12384655
    [No Abstract]   [Full Text] [Related]  

  • 37. Barnyard biotech--lame duck or golden goose?
    Powell K
    Nat Biotechnol; 2003 Sep; 21(9):965-7. PubMed ID: 12949546
    [No Abstract]   [Full Text] [Related]  

  • 38. Growing against the grain.
    Boyle M
    Fortune; 2004 May; 149(9):148-9, 152, 154 passim. PubMed ID: 15124331
    [No Abstract]   [Full Text] [Related]  

  • 39. What mergers can do for you.
    Acharya A
    Nat Biotechnol; 2011 Jun; 29(6):477-9. PubMed ID: 21796820
    [No Abstract]   [Full Text] [Related]  

  • 40. Troubled UK biotech firm faces new probe.
    Masood E
    Nature; 1998 Apr; 392(6679):852. PubMed ID: 9582060
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.